Institution-Grade Tools, Priced for Individual Investors.
Receive trading alerts directly to your inbox. Try Barchart Plus or Barchart Premier for free today.
/Facebook%20on%20a%20phone%20by%20Firmbee_com%20via%20Unsplash.jpg)
/Moderna%20Inc%20meds-by%20Ascannio%20via%20Shutterstock.jpg)
September S&P 500 E-Mini futures (ESU25) are trending up +0.32% this morning, capping a week dominated by tariff and geopolitical developments, as well as a wave of earnings, with investors weighing U.S....
/The%20Duolingo%20owl%20displayed%20on%20a%20smartphone%20screen_%20Image%20by%20El%20editorial%20via%20Shutterstock_.jpg)
Duolingo stock soars on a strong Q2 release and raised guidance for the full year. But is now the right time to load up on DUOL shares?
/Uber%20and%20Lyft%20by%20Thought%20catalog%20via%20Unsplash.jpg)
Lyft is the underdog in the ride-hailing space to Uber, but for the patient trader, it could still end up in the Hall of Fame.
/A%20concept%20image%20of%20a%20self-driving%20car%20image%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
Nebius stock is rallying on a strong Q2 and raised its full-year guidance. Here’s how you should play NBIS shares following the post-earnings surge.
/Citigroup%20Inc%20logo%20Miami%20location-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Citigroup had four unusually active put options on Wednesday. While the risk/reward of selling any of the three puts expiring in nine days is attractive, the one expiring in nearly a year might be a better...
With Phase 3 results for its lead psychedelic therapy expected next year, is now the right time to take a bold bet on MNMD stock?
Intel stock slides as President Donald Trump demands CEO Lip-Bu Tan’s immediate resignation. Seaport Global recommends steering clear of INTC shares in 2025.
/Boeing%20Co_%20plane-by%20Wirestock%20via%20iStock.jpg)
As Boeing’s CEO hopes for a turnaround this year, is now the right time to buy into the stock?
Another biotech company shifts toward becoming a crypto treasury company, this time focusing on Ethereum.
Eli Lilly is poised for a major boost as new data shows its diabetes drug Mounjaro offers heart health benefits, potentially making it the top choice for patients with Type 2 diabetes.
